Teligene
Nanjing
About Teligene
Teligene was established in 2011. It is a high-tech pharmaceutical research and development company focusing on the research and development and industrialization of small molecule innovative drugs. The company's senior technical management team is experienced and familiar with cutting-edge drug development technologies and development trends at home and abroad. The company mainly aims to research and develop hot spots and develop trends of new international small molecule targeted anti-tumor drugs, and designs, screens, optimizes and develops original small molecule targeted anti-tumor drugs with independent intellectual property rights.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $92.9M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2021)
- Website: teligene.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/teligene-8456 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.